Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEAC (2-propyl pentanoic acid) for colorectal polyps in familial adenomatous polyposis
2006-001886-40Phase 2Completed
- Sponsor
- TopoTarget
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Colonic Adenomatous Polyposis and colonic polyp comparing PEAC minitablets (valproic acid) with Placebo (2 arms). Primary endpoints: Primary efficacy endpoint and Primary safety endpoint. Started Apr 2006; status: completed.
02
Drugs
valproic acid
03
Conditions
Colonic Adenomatous Polyposiscolonic polyp
Beyond the preview
Go deeper on 2006-001886-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001886-40.